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Summary
The innate immune system is the most ancestral and
ubiquitous system of defence against microbial infec-
tion. The microbial sensing proteins involved in innate
immunity recognize conserved and often structural
components of microorganisms. One class of these
pattern-recognition molecules, the Toll-like receptors
(TLRs), are involved in detection of microbes in the
extracellular compartment whereas a newly discov-
ered family of proteins, the NBS-LRR proteins (for
nucleotide-binding site and leucine-rich repeat), are
involved in intracellular recognition of microbes and
their products. NBS-LRR proteins are characterized
by three structural domains: a C-terminal leucine-rich
repeat (LRR) domain able to sense a microbial motif,
an intermediary nucleotide binding site (NBS) essen-
tial for the oligomerization of the molecule that is
necessary for the signal transduction induced by dif-
ferent N-terminal effector motifs, such as a pyrin
domain (PYD), a caspase-activating and recruitment
domain (CARD) or a baculovirus inhibitor of apopto-
sis protein repeat (BIR) domain. Two of these family
members, Nod1 and Nod2, play a role in the regulation





by bacterial ligands. Recently, it was shown that Nod2
recognizes a specific peptidoglycan motif from bac-
teria, muramyl dipeptide (MDP). A surprising number
of human genetic disorders have been linked to NBS-
LRR proteins. For example, mutations in Nod2, which





B activation when stimulated, are associ-
ated with susceptibility to a chronic intestinal inflam-
matory disorder, Crohn’s disease. Conversely,
mutations in the NBS region of Nod2 induce a consti-




B and are responsible for Blau
syndrome, another auto-inflammatory disease. Nalp3,
which is an NBS-LRR protein with an N-terminal Pyrin
domain, is also implicated in rare auto-inflammatory
disorders. In conclusion, NBS-LRR molecules appear
as a new family of intracellular receptors of innate
immunity able to detect specific bacterial compounds
and induce inflammatory response; the dysregulation
of these processes due to mutations in the genes




All animals and plants possess a means of innate defence
against microbial attack. In most organisms, this system
represents the sole mechanism for protection against
infection; only vertebrates possess in addition to this, an
adaptive immune system for selective protection against
specific microbes. Innate immune systems of both plants
and animals rely on surveillance proteins to recognize
microbes that interact with the host cell. Strikingly, the
microbial recognition proteins of such diverse hosts share
common protein signatures implying evolutionary conser-








., 2001). The recognition mole-
cules involved in host defence possess a microbial-ligand
sensing domain, which is often made up of a series of
leucine-rich repeat (LRR) units, and a protein–protein
interaction domain that links microbial recognition to sig-
nal transduction pathways to initiate the defensive
response. We make a distinction at this point of stating
ligand ‘sensing’ rather than ligand ‘binding’, as only in a
few cases has direct interaction between the microbial
ligand and recognition molecule been demonstrated.
Thus, we will use the term ‘pattern-recognition molecules’
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the factors that are recognized by PRMs are normally
structural components of the microbe like lipopolysaccha-
ride (LPS) or other components of the cell wall. These
components are termed ‘pathogen-associated molecular
patterns’ or PAMPs because they are, by and large, con-
served among diverse sets of microorganisms (Medzhitov
and Janeway, 1998).
Pattern-recognition molecules either present their
ligand sensing domains extracellularly or intracellularly. In
mammals, the Toll-like receptor (TLR) family represents
membrane-bound PRMs that detect PAMPs in the extra-
cellular environment (Barton and Medzhitov 2002). More
recently, a family of intracellular proteins has been discov-
ered that likely represents a means of cytosolic surveil-
lance; these intracellular PRMs mediate host defence by














., 2003). This class of PRMs includes the
Nod (for nucleotide-binding oligomerization domain) and
Nalp (for NACHT, LRR and PYD domains; see below)
proteins, which possess a central nucleotide-binding site
(NBS) and a C-terminal LRR domain, thus classifying
them into a new family of proteins termed NBS-LRR (see
below). This review will focus primarily on a few of these
family members and the role of these intracellular PRMs
in host defence and human disease. For more details on
TLRs as well as the NBS-LRR family in general, we direct
the reader to the following excellent reviews on this sub-





















The NBS-LRR family of proteins
 
The NBS-LRR family of proteins was recently identified
and the role of these intracellular proteins in host defence
is beginning to be elucidated. The defining feature of the
NBS-LRR family of cytoplasmic proteins is a tripartite
domain structure with a C-terminal LRR domain, a cen-
tral NBS domain or NACHT (for neuronal apoptosis
inhibitor protein, CIITA, HET-E and TP1) and at the N-
terminus, a protein–protein interaction domain, CARD
(caspase-activating and recruitment domain), PYD (pyrin
domain), or BIR (baculovirus inhibitor of apoptosis pro-














family has also been termed ‘CATERPILLER’, which is an
acronym for CARD, transcription enhancer, R- (purine-)





presence of these different N-terminal domains divides
these proteins into subfamilies, for example, Nalps con-
tain PYD, Nods possess CARD domains and NAIP (for
neuronal apoptosis inhibitor) have BIR domains (see
Fig. 1). In terms of domain structure, these proteins
resemble disease resistance proteins in plants, which
first led to the speculation that they may play similar roles





In both plant R proteins and in TLRs, the LRR domain
is involved in ligand sensing suggesting that is also likely





Furthermore, deletion of the LRR domain of Nod1 or
Nod2 renders these molecules insensitive to their bacte-




., 2001). This domain in the
NBS-LRR family is predicted to form a non-globular
horse-shoe configuration based on the crystal structure
of a prototypical protein possessing this domain, the por-
cine and human ribonuclease inhibitors (Kobe and
Deisenhofer, 1993; Kajava and Kobe 2002). Proteins that
possess LRRs are implicated in the interaction with a
great diversity of ligands, demonstrating the binding ver-
satility of this structural motif (Kobe and Deisenhofer,
1994).
The NBS domain contains a number of distinct motifs
including the Walker A and Walker B motifs, which are the







respectively. This domain mediates oligomerization of
NBS-LRR proteins and is predicted to bind ATP, except





prehensive mutational analyses of CIITA, have revealed
that the nucleotide binding domain is essential for the
oligomerization of the molecule and its subsequent trans-




., 2001). By comparison,
it is likely that this domain in other NBS-LRR proteins
would bind nucleotides that would then regulate the activ-
ity of the molecule.
The N-terminal PYD and CARD domains of the NBS-
LRR proteins mediate homophilic interactions between
other molecules carrying these motifs. Both PYD and
CARD are members of the death domain-fold superfam-
ily that also includes death domains and death effector
domains. Members of this family are involved in apopto-





and DiStefano 2000). CARD domains are found in a
number of pro-apoptotic proteins like caspase 1 and
caspase 9. In the case of Nod1 and Nod2, this domain
mediates the activation of a pro-inflammatory cascade
through its interaction with the CARD domain of Rip2
(for receptor-interacting protein 2; also known as RICK


















2001). The PYD domain is also implicated in pro-
inflammatory processes. This domain was first
described in Pyrin, a protein whose gene is mutated in
patients that suffer from a hereditary disorder called





Bertin and DiStefano 2000).
 
















Using a genomic database mining approach to search for









(1999) discovered Nod1/CARD4. Similar to Apaf-1, Nod1
has a N-terminal CARD domain and central NBS/NACHT,
but instead of the WD repeats found in Apaf-1, Nod1 has
an LRR domain. Biochemical investigation into the signal-
ling pathways induced downstream of Nod1 demonstrated
that Nod1 oligomerization is sufficient to induce the










is an adapter protein sharing homology with IRAK, RIP
proteins (involved in signalling pathways downstream of









., 1998). Subsequently, the interaction




B pathway through the recruitment of the IKK complex





natively, it has been proposed that Nod1 could enhance





., 2002). Based on these observations,
oligomerization of Nod1 seems to represent a key initial
event allowing the induction of downstream pro-
inflammatory signals. Therefore, it is a critical issue to
define what is the natural trigger of Nod1 oligomerization.
In parallel with the studies on the activation of Apaf-1, it
is conceivable that oligomerization of Nod1 is preceded
by sensing of a specific ligand through the C-terminal LRR
domain; indeed, Apaf-1 detects cytochrome C through its
C-terminal WD repeat domain, allowing unfolding of the
molecule and oligomerization (Adrain and Martin 2001).
Recently, we have shown that infection of epithelial cells




 is sufficient to





B pathway through the recruitment of Rip2 and




., 2001). This observation
suggests that Nod1 is able to detect a bacterial motif





 into epithelial cells. Moreover, several reports
have shown that commercial preparations of LPS can

















NBS-LRR family of proteins. Domain 
structures are shown for the subfamilies of 
NBS-LRR proteins, Nods, Nalps, Ipafs and 
CIITA. For CIITA, brackets are shown around 
the CARD domain as this domain is found in 
a subtype of CIITA molecules expressed in 





CARD, caspase-activating and recruitment 
domain; NBS, nucleotide binding site; LRR, 
leucine-rich repeat; PYD, pyrin domain; BIR, 
baculovirus inhibitor of apoptosis protein 
repeat; AD, activation domain; Nod, nucle-
otide-binding oligomerization domain; Nalp, 
NACHT (for neuronal apoptosis inhibitor pro-
tein, CIITA, HET-E and TP1)-, LRR- and 
PYD; Ipaf, ICE (interleukin-1 converting 
enzyme) protease activating factor; Naip, 
neuronal inhibitor of apoptosis; CIITA, class 
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ellular sensor of LPS is probably premature; indeed, Nod2
is also able to detect commercial preparations of LPS, but
three recent reports have shown that this sensing was
likely due to contamination of LPS preparations with a














More recently, our laboratory and that of Dr Naohiro










Strikingly, Nod1 also senses a peptidoglycan motif but
unlike Nod2, the motif sensed by Nod1 is found mainly in
the peptidoglycan from Gram-negative bacteria. The nat-









-acetylmuramic acid substituted with
a tripepetide group where the terminal amino acid is a





2003a). Most Gram-positive organisms have a lysine res-
idue in this position in their peptidoglycan structure and
this motif is not recognized by Nod1. Furthermore, using








-glutamyl-mesoDAP is sufficient for Nod1 activation indi-





., 2003b). Therefore, it is likely that
meso-DAP containing peptidoglycan fragments contami-
nate commercial LPS preparations leading to the activa-
tion of Nod1. Taken together, these studies point to the
conclusion that Nod1 is indeed an intracellular PRM that
triggers the activation of pro-inflammatory signalling path-
ways following detection of a peptidoglycan motif from
Gram-negative bacteria. Our findings also demonstrate
that Nod1 is the sole surveillance system in epithelial cells
as Gram-positive bacteria are not detected in these cells.
Moreover, epithelial cells isolated from mice deficient in
Nod1 do not detect Gram-negative bacterial products




., 2003a). The implications of these findings suggest
that at least in the basal state, epithelial cells, like those
that line the intestinal tract, have only the Nod1-dependent
Gram-negative bacterial sensing system, perhaps reflect-





Following the identification of Nod1, Nod2, a second Nod
molecule predominantly expressed in cells of the myeloid
lineage, was discovered. Nod2 shares significant homol-
ogy with Nod1, but unlike Nod1, possesses two CARD




., 2001b; Fig. 1).
The initial characterization of the signalling pathways trig-
gered by Nod2 also revealed similarities with the pathways
downstream of Nod1. Indeed, the Nod2 pathway is
induced following oligomerization through the recruitment









., 2001b). The initial studies carried out
to identify the nature of the motif detected by Nod2 sug-
gested that intracellular presentation of LPS could trigger




., 2001). However, our
group recently demonstrated that whereas commercial
preparations of LPS stimulate Nod2, further purification of
the LPS abolishes the effect, demonstrating that a bacte-
rial contaminant present in such LPS preparations was





2003a). We could then identify peptidoglycan as the active
contaminant. Moreover, our group and that of Gabriel
Nuñez further identified that a specific peptidoglycan motif,
muramyl dipeptide (MDP), was the specific bacterial ligand









., 2003). Because MDP has been known for
decades for its adjuvant properties on macrophages (MDP




., 1974), these observations strongly suggest that
Nod2 is responsible for the immuno-modulatory function
of this bacterial molecule.
Although Nod2 expression was first thought to be
restricted to cells of the myeloid lineage, recent studies
have demonstrated that Nod2 mRNA can be detected in













More importantly, Nod2 expression can be induced in
















., 2003), a mecha-
nism that may explain the overactivation of the Nod2-
mediated pathway in inflamed colonic tissues of Crohn’s




., 2003; Fig. 2). Therefore,
inflammation might trigger the induction of Nod2 in cells
such as the epithelial cells lining mucosal surfaces, which
represent one of the first cell populations encountered by
an invasive pathogen. Because Nod2 is able to sense the
presence of Gram-negative or Gram-positive bacteria in
the cytosolic compartment through the detection of MDP,
the upregulation of Nod2 in these cells is therefore likely
to contribute to the early innate immune defence against





. (2003) recently uncovered a new function of
Nod2 in intestinal epithelial cells. The authors have impli-




 once these bacte-
ria are inside epithelial cells.
Taken together, several lines of evidence clearly identify
Nod2 as a new intracellular PRM involved in innate
immune defence against bacteria, not only in macroph-
ages but also in epithelial cells from inflamed mucosal
surfaces. The fact that Nod2 has also been independently









., 2001a; see below)
suggests intriguing interconnections between bacterial
sensing/killing and inflammatory diseases.
 
















Nalps are NBS-LRR proteins that, instead of the CARD
domain(s) found in Nod1 or Nod2, all contain a PYD
domain at their N-terminal end (Fig. 1). Similar to the
CARD domain of Nods, the PYD domain exclusively medi-
ates PYD–PYD homophilic interactions (Bertin and DiS-




., 2001). Through genomic




. (2003) have defined 14
Nalps in the human genome. Nalp2–14 all exhibit the
following tripartite structure: PYD-NBS-LRR. Interestingly,
an additional CARD domain is found at the C-terminal end
of Nalp1. Moreover, ASC/PYCARD, an adaptor molecule
containing an amino-terminal PYD domain and a carboxy-









 2002a). Therefore, Nalps
can interact also with CARD containing molecules as has




., 2003), or CARD-
containing Caspases (Caspase-1 or Caspase-5) through





(2002) have recently uncovered a key function of Nalps
by showing that Nalp1 and ASC/PYCARD can form a
molecular platform, termed the inflammasome, allowing
the recruitment of Caspase-1 and Caspase-5, followed by
the activation of these pro-inflammatory caspases. More-
over, Nalp3 has been shown to form a complex involving










The mechanism that triggers the formation of the
inflammasome remains obscure. Because all Nalps con-
tain an LRR domain, it is possible that Nalps are activated
in a similar way as Nods through the LRR-dependent





(2002) have observed that rupture of the cell integrity is
sufficient to induce the formation of the inflammasome,
suggesting that Nalps may be activated by a cellular com-
ponent released after the destruction of cellular
organelles. In this case, the activation of Nalps would
represent a ‘danger’ response to major cellular damage,
in a similar manner to that described for the activation of
 
Fig. 2. Model for a role of Nod1 and Nod2 
as cytosolic surveillance proteins of mucosal 
surfaces. Nod1 and Nod2 expressed by 
epithelial cells lining the intestinal surface 
and underlying macrophages maintain the 
mucosa in a basal state of inflammation. In 
conditions of bacterial infection and infiltra-
tion of the tissue, signals emanating for the 
epithelial surface via the activation of NF-kB, 
as well as bacterial products present in the 
submucosa (like LPS, lipoproteins, PG and 
MDP) trigger underlying immune cells such 
as antigen-presenting cells (APC) to recruit 
the involvement of the adaptive immune 
system. Subsequent signalling by these 
cells, in the form of TNFa and IFNg, 
upregulate Nod expression in the tissues in 
order to amplify the response.
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the Apaf-1 pathway by the release of cytochrome c from
the mitochondria (Adrain and Martin 2001). Alternatively,
as all 14 Nalps each contain an LRR domain, it will be of
interest to define if some Nalps could be activated through
the detection of microbial patterns. This is a likely hypoth-
esis since it has been shown that commercial prepara-
tions of LPS trigger the formation of the inflammasome in
macrophages (Martinon et al., 2002). Whether this effect
is mediated by LPS itself or by contaminants present in
commercial LPS preparations remains to be defined.
NBS-LRR proteins and genetic diseases
A number of mammalian diseases have been shown to
be linked with mutations in the genes encoding some of
the NBS-LRR family members and associated proteins
(Table 1). Remarkably, mutations in the genes encoding
Nod2 and Nalp3 are together associated with five distinct
genetic disorders characterized by aberrant inflammation
(Ogura et al., 2001a; Hoffman et al., 2001; Hugot et al.,
2001;  Miceli-Richard et al., 2001; Aganna et al., 2002;
Aksentijevich et al., 2002; Feldmann et al., 2002). More-
over, mutations in the genes encoding CIITA, Pyrin and
Naip5 are associated with inflammatory disorders and
susceptibility to bacterial infection (Steimle et al., 1993;
The French FMF consortium, 1997; The international FMF
consortium, 1997; Diez et al., 2003; Wright et al., 2003).
These striking observations reveal the importance of this
family in regulating the homeostasis of the immune sys-
tem. We will restrict this discussion to Nod2-, Nalp3-, and
Naip-associated diseases.
I. Nod2 and predisposition to Crohn’s disease
Crohn’s disease (CD) is a periodic and lifelong auto-
inflammation of the digestive tract associated with granu-
loma formation. Patients suffering from CD exhibit serious
painful attacks of the gastrointestinal mucosa resulting in
severe diarrhoea, bleeding, fever and malnutrition. The
aetiology of CD remains unknown, although the patholog-
ical intestinal inflammatory response is thought to be a
consequence of a breakdown of tolerance to bacterial
flora in the gastrointestinal tract of genetically predisposed
individuals (Podolsky 2002). Crohn’s disease normally
arises in the second or third decade of life and affects
approximately one million Northern Americans and West-
ern Europeans. Since the 1940s, the incidence of CD has
dramatically increased in European-native and associated
countries (Kurata et al., 1992) and more recently in pop-
ulations of east Asian and African descent which have
adopted a more ‘westernized’ lifestyle (Probert et al.,
1993). These findings suggest the influence of a yet
unknown environmental factor that favours the develop-
ment of CD. On the other hand, similar to other known
multifactorial disorders including multiple sclerosis and
psoriasis, the rate of incidence of CD among monozygotic
twins is approximately 10 fold higher than for dizygotic
twins (Thompson et al., 1996; Orholm et al., 2000). Famil-
ial/ethnic aggregations (i.e. in Ashkenazi Jewish popula-
tions; Roth et al., 1989) and segregation studies (Kuster
et al., 1989) also strongly suggest the influence of genetic
factors in the aetiology of CD, and more precisely the
presence of recessive genetic determinants with incom-
Table 1. Human and animal diseases associated with mutations in NBS-LRR proteins.
NBS-LRR
protein Other names Associated diseasesa Predicted defecta
Nod subfamily
Nod2 Card15 Crohn’s disease Defective bacterial ligand sensing/other?
Blau syndrome Constitutive (i.e. ligand-independent)
activation of NF-kB
Nalp subfamily
Nalp3 Pypaf1, CIAS1 Cryopyrin, Muckle-Wells syndrome (MWS) Ligand-independent activation of 
caspase 1; increased IL-1b secretion







Naip Birc1 Spinal muscular atrophy (Roy et al.,
1995)
Failed caspase inhibition
(Liston et al., 1996).
Naip5 (murine) Birc1e Susceptibility to Legionella
pneumophila infection
as above or lack of bacterial sensing?
CIITA subfamily
CIITA Bare lymphocyte syndrome
(Steimle et al., 1993)
Lack of MHCII expression due to no
nuclear transolcation
NBS-LRR-associated proteins
Pyrin Marenostrin Familial Mediterranean fever Defective bacterial ligand sensing and
apoptosis (Chae et al., 2003)
a. See text for references except for those indicated.
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plete penetrance. Finally, the influence of genetic varia-
tions is demonstrated from evidence of linkage studies in
humans and in vivo dissection of targeted or spontaneous
immune gene-deficient animals. Using a positional cloning
strategy in out-bred European populations, three genetic
variations of Nod2 have been independently associated
with a predisposition to CD (Hugot et al., 2001). Following
the alternate gene candidate approach, another group
demonstrated independently the association between CD
and one of these three Nod2 variants, the 1007-frame shift
mutation. This frame-shift mutation, which predicts a trun-
cated protein lacking the terminal LRR, is the most com-
mon form of Nod2 mutation associated with CD and acts
as a loss-of-function mutation in the sensing of bacterial
ligands (Ogura et al., 2001a).
More than 90% of the mutated alleles associated with
CD affect the LRR region, suggesting a crucial role of this
domain in the development of CD (Lesage et al., 2002).
However, of the 32 distinct mutated alleles of Nod2 that
have been studied, 13 show a defect in peptidoglycan
sensing and/or an impairment in NF-kB activation. Of
these, only four are in the LRR domain, including the most
common Nod2 mutation associated with CD, the 1007
frame-shift mutation (Chamaillard et al., 2003a). Although
these findings suggest that, in most cases of Nod2-
associated CD, impaired NF-kB activation by bacterial
ligands is associated with disease (Fig. 3), factors other
than those relating to NF-kB activation must be involved.
Since Nod2 is also implicated in the activation of apopto-
sis (Ogura et al., 2001b) it is possible that dysregulation
of apoptotic pathways due to mutations in Nod2 leads to
aberrant inflammation.
II. Gain of function mutations of Nod2 causing
Blau syndrome
Mutations in Nod2 have also been associated with Blau
syndrome, a rare autosomal dominant disorder in which
patients present with associated arthritis, uvetis, skin
rashes and granuloma. Miceli-Richard and colleagues
linked three mutations with this disease, implicating two
distinct codons (R334Q-W and L469F) of the NBS-
associated domain of Nod2 (Miceli-Richard et al., 2002).
The two mutations at codon 334 were retrieved in five
other distinct families (Wang et al., 2002b) supporting the
hypothesis of a recurrent mutation. Surprisingly, the
homologous position of this codon in the related NBS-
LRR protein Nalp3 (i.e. R260W) is also recurrently
mutated in Muckle–Wells Syndrome (MWS) and familial
cold autoinflammatory syndrome (FCAS) suggesting a
common pathogenic mechanism of these structurally
related proteins (Hoffman et al., 2001; Aganna et al.,
2002; see below).
Constitutive NF-kB activation (i.e. independent of any
exogenous stimulation) has been associated with the
three reported mutations causing Blau syndrome (Cha-
maillard et al., 2003a; Fig. 3). Further studies are now
required to confirm this observation for the dominant
mutations in the Nalp3 gene (e.g. uncontrolled NF-kB and/
or apoptosis activation) and to document the physiological
outcome of this stimulus-independent NF-kB activation
(i.e. constitutive activation of Rip2, altered ATP binding,
constitutive association to binding partners, turn-over,
etc.).
III. Nalp3 and autoinflammatory disorders
The discovery of mutations in Nod2 associated with CD
and Blau syndrome then provoked the screening of
related NBS-LRR proteins in others inflammatory
disorders. A Nalp subfamily member, Nalp3 (also known
as Cryopyrin, Pypaf1 or Cias1; Manji et al., 2002),
encoded by the cias1 gene, has been recently associated
with the expression of a broad phenotypic spectrum of
dominantly inherited autoinflammatory disorders, includ-
ing Muckle–Wells Syndrome (MWS), familial cold autoin-
flammatory syndrome (FCAS) (Hoffman et al., 2001;
Aganna et al., 2002; Dode et al., 2002) and chronic neu-
rologic cutaneous and articular syndrome (CINCA; Feld-
mann et al., 2002), also called NOMID (for neonatal onset
multisystem inflammatory disease; Aksentijevich et al.,
2002; see Fig. 3). All three of these disorders are charac-
terized by recurrent inflammatory crises that are associ-
ated with fever, rash and arthritis. The major difference
among these disorders is that, as suggested by the name,
FCAS is precipitated by cold, whereas MWS and CINCA
are chronic disorders with no specific trigger for the
disease.
At least 22 distinct missense mutations, including 20 de
novo mutational events, of the cias1 gene, encoding the
Nalp3 protein, are associated with MWS, FCAS and
CINCA (Aksentijevich et al., 2002). All of these mutations
are within the NBS and NBS-associated domains. Nota-
bly, three mutations (V198M, D303N and R260W) are
predisposing to the three syndromes suggesting the exist-
ence of modifying genes and/or environmental factors
modulating the phenotypic expression. Knock-in and/or
transgenic models with, for example, the R260W Nalp3
mutation, will help to investigate pathogenic mechanism
and develop rational treatment for this disease.
IV. Naips: spinal muscular atrophy and susceptibility of 
mice to Legionella pneumophila infection
Because of its sequence similarity to Ipaf in the NBS and
LRR domains, Naip is included in this subfamily of NBS-
LRR proteins (Fig. 1; Tschopp et al., 2003). Ipaf, which
contains an N-terminal CARD domain, is an activator of
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Fig. 3. Possible mechanisms involved in human inflammatory diseases due to mutations in Nod2 and Nalp3. In the case of Crohn’s disease, 
lack of muramyl dipeptide sensing due to mutations in the LRR domain of Nod2 prevent ligand triggered Rip2 association through homophilic 
CARD–CARD interactions and subsequent activation of NF-kB (Ogura et al., 2001; Girardin et al., 2003; Inohara et al., 2003). For Blau syndrome, 
mutations of Nod2 falling in the NBS region lead to constitutive activation of NF-kB and a constant stimulation of the inflammatory response 
(Chamaillard et al., 2003a). Pyrin, which is an adaptor likely involved in regulating Nalp3 activity by preventing ASC association (Dowds et al., 
2003), is mutated in Familial Mediterranean Fever (FMF). This mutation likely results in amplified and unchecked Nalp3 activity. Mutations in the 
NBS-associated domain of Nalp3 are associated with three disorders: familial cold–autoinflammatory syndrome (FCAS), Muckle–Wells syndrome 
(MWS), and chronic infantile neurologic, cutaneous, articular syndrome (CINCA). These mutations likely lead to constitutive association of Nalp3 
with its adaptor, ASC, leading to NF-kB, apoptosis and IL-1b generation (Srinivasula et al., 2002).
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caspase activity. In contrast, through its N-terminal BIR
region, Naip inhibits effector caspases. In humans, muta-
tions in Naip have been linked to the development of
spinal muscular atrophy, which is a neurodegenerative
disease characterized by progressive degeneration of
lower motor neurons. Consistent with this phenotype,
Naip appears to be mainly expressed in neurons where
its role is to protect cells against apoptosis.
More recently, polymorphisms in mouse Naip5 have
been associated with susceptibility to Legionella pneumo-
phila infection (Diez et al., 2003; Wright et al., 2003).
These findings stemmed from the observation that mac-
rophages isolated from two different inbred strains of mice
differ in their permissiveness to intracellular Legionella
replication. In human macrophages, Legionella is capable
of intracellular growth in specialized phagosomal com-
partments. However, in most inbred mice strains, isolated
macrophages are non-permissive for Legionella replica-
tion. The one exception to this rule so far examined is the
A/J strain of mouse. In vitro, macrophages from these
mice allow intracellular replication of Legionella. This phe-
notype difference segregates in Mendelian fashion and
was shown to be controlled by the Lgn1 locus on chromo-
some 13. Using similar approaches, two groups identified
the gene within this locus that is responsible for this phe-
notype as Naip5 (Diez et al., 2003; Wright et al., 2003).
What is the possible mechanism by which Naip5 confers
resistance to Legionella replication in mouse macroph-
ages and what are the implications in human infection with
this pathogen? So far, an association between apoptosis
and Naip5-regulated Legionella replication has not been
found (Diez et al., 2003; Wright et al., 2003). Therefore, it
is plausible that Naip5 may be detecting a Legionella-
specific virulence factor that then triggers a yet unidenti-
fied antibacterial response in macrophages restricting the
growth of this pathogen.
Future prospects
The recent characterization of the NBS-LRR family of
intracellular proteins has allowed for the definition of a new
paradigm connecting microbes and inflammation/inflam-
matory diseases. The originality of this emerging field of
research certainly comes from the convergence of the
disciplines of biochemistry and genetics. Indeed, using
biochemical approaches, NBS-LRR proteins have been
discovered as new intracellular sensors of bacterial
patterns, such as Nod1, Nod2, and possibly Nalps. In
parallel, a striking number of the genes encoding the NBS-
LRRs have been found associated with susceptibility loci
for inflammatory disorders. The best example of such
convergence is undoubtedly supported by the discovery
that Nod2 functions as a sensor of MDP, and that Nod2
is the first identified susceptibility gene for Crohn’s dis-
ease. These studies provide a new support for the well-
documented hypothesis suggesting that inflammatory dis-
orders such as IBD could be triggered by a breakdown of
immune tolerance to commensal luminal flora. However,
rather than assigning a definitive mechanistic explanation
for the occurrence of these disorders, the characterization
of the key role played by the NBS-LRR proteins in bacterial
sensing and inflammation opens puzzling new questions.
An obvious central question arising from the studies on
Nod2 is how are defects in bacterial sensing due to muta-
tions in Nod2 associated with chronic inflammation and
predisposition to Crohn’s disease? Paradoxically, bio-
chemical evidence suggests that bacterial sensing by
PRMs from the innate immune system, such as TLRs and
Nods, trigger the activation of pro-inflammatory pathways.
Examples of such pro-inflammatory pathways include the
activation of NF-kB, p38 and JNK, which leads to the
expression of numerous cytokines and chemokines.
Therefore, these observations are difficult to reconcile at
the cellular level. Most probably, the right model will have
to be defined at the level of the tissue, where homeostasis
plays a central role. For instance, it can proposed that in
normal conditions, a constant sampling of the microbial
environment by cells of the mucosal surfaces (i.e epithelial
cells or resident macrophages) leads to a physiological
baseline level of inflammation. This constant immune sur-
veillance provided by Nods, and possibly also TLRs, not
only plays a role in steady-state basal conditions, but can
also initiate a robust pro-inflammatory defence response
following pathogenic stimuli. Therefore, the amplitude of
inflammatory signals originating from mucosal surfaces is
likely what defines the nature of the response driven by
the adaptive immune system. Following this hypothesis,
basal levels of inflammation stay below the threshold nec-
essary to recruit cells of the adaptive immune system,
whereas above this threshold, amplified inflammation
drives involvement of this system (Fig. 2). Then, the char-
acterization of defective bacterial sensing by mutated
Nod2 associated with Crohn’s disease leads to the follow-
ing question: how does the adaptive immune system inter-
pret the absence of a signal?
However, this failure to transduce bacterial-induced
inflammatory signals (as exemplified by the 1007fs muta-
tion in Nod2, the most common Nod2 mutation associated
with CD) is not a general feature of CD-associated Nod2
mutations. Indeed, by systematically analysing the ability
of 32 individual CD-associated Nod2 mutations to trans-
duce pro-inflammatory signals either in basal conditions
or in response to peptidoglycan, Chamaillard et al.
(2003a) have demonstrated the heterogeneity of the
defects associated with Nod2 mutations towards bacterial
sensing. Hence, 40% of CD-associated Nod2 mutations
lead to an inactive molecule, in either basal or
peptidoglycan-stimulated conditions. Three mutants
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(R713C, E843K and 1007fs) display a Nod2 molecule still
able transduce the NF-kB signal but which can no longer
respond to peptidoglycan stimulation. For half of the other
mutants, no defect in transducing the pro-inflammatory
signal induced by peptidoglycan could be observed, indi-
cating that Nod2 is also implicated in other cellular pro-
cesses. Alternatively, these findings may suggest a high
mutational rate, as observed in different strains of mice,
that may be driven by positive selection (Ogura et al.,
2003).
One such example of a newly described function for
Nod2 is its direct antibacterial activity in intestinal epithe-
lial cells (Hisamatsu et al., 2003). So far, the mechanism
that allows these cells to kill intracellular Salmonella typh-
imurium remains unknown. A possible mechanism could
involve the re-routing of the Salmonella phagocytic vacu-
ole to lysosomes, as this phenomenon has been
described in macrophages pretreated with MDP (Mukher-
jee et al., 2002), the bacterial molecule sensed by Nod2.
It will be of interest to define if Nod2 displays a similar
antibacterial activity on enteric invasive bacteria that
escape their phagocytic vacuole such as Shigella flexneri.
Although the role of NBS-LRR proteins in innate
immune defence remains largely unknown, recent
progress has led to the characterization of some of the
signalling pathways that they trigger. An important chal-
lenge is now to define what are the molecular motifs
(microbial or from the host) that activate each individual
member of this family. Moreover, it will be of importance
to define if these NBS-LRRs directly interact with their
activating agonists or if co-receptors are required to
achieve sensing. Only then will we be able to understand
how mutations of these NBS-LRR proteins can favour
susceptibility to complex inflammatory diseases.
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